We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
DiscoveRx and BioFocus Announce Co-marketing Agreement for GPCR Screening
News

DiscoveRx and BioFocus Announce Co-marketing Agreement for GPCR Screening

DiscoveRx and BioFocus Announce Co-marketing Agreement for GPCR Screening
News

DiscoveRx and BioFocus Announce Co-marketing Agreement for GPCR Screening

Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "DiscoveRx and BioFocus Announce Co-marketing Agreement for GPCR Screening"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

BioFocus® and DiscoveRx corp. announced has that they have signed a co-marketing agreement that allows BioFocus to perform screening on behalf of BioFocus’ customers using DiscoveRx PathHunter™ ß-Arrestin GPCR screening assay, HitHunter™ cAMP assays and associated cell lines.

DiscoveRx has a portfolio of non-force coupled GPCR cell lines utilizing its award winning PathHunter™ ß-Arrestin GPCR platform as well as HitHunter™ cAMP detection. These validated cell lines and associated detection platform have been used in numerous drug discovery campaigns for de-orphanization and identifying novel hits.

“The addition of the DiscoveRx GPCR product portfolio to BioFocus will enhance our assay development and screening platform” said Chris Newton, SVP BioFocus. “Our customers will gain advantage of our expertise coupled with the unique and complete GPCR portfolio offered by DiscoveRx”.

”We are pleased that BioFocus and DiscoveRx have forged a partnership as both parties bring novel and unique capabilities and technologies to meet challenges of drug discovery customers” said Pyare Khanna, CEO of DiscoveRx.
Advertisement